Kolexia
Pernot Simon Gastro-entérologie
Pernot Simon
Gastro-entérologie
Institut Bergonié
Bordeaux, France
222 Activités
247 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Métastase tumorale Adénocarcinome Carcinomes Tumeurs du foie Tumeurs de l'estomac Tumeurs du pancréas Tumeurs de l'anus Tumeurs du côlon

Collaborateurs

Voir plus
Taieb Julien
Taieb Julien
Hôpital Européen Georges Pompidou, Paris, France
Tougeron David
Tougeron David
Hôpital La Miletrie, Poitiers, France
Smith Denis
Smith Denis
Hôpital Saint-André, Bordeaux, France
De La Fouchardiere Christelle
De La Fouchardiere Christelle
Centre Paoli-Calmettes, Marseille, France

Industries

Voir plus
Servier
20 collaboration(s)
Dernière en 2023
Merck-Serono
14 collaboration(s)
Dernière en 2022
Sanofi
9 collaboration(s)
Dernière en 2021
Pierre Fabre
9 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
HERIZON-GEA-01: A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination With Chemotherapy With or Without Tislelizumab in Subjects With HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA)
Essai Clinique (Jazz Pharmaceuticals)   04 mars 2024
Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   24 février 2024
TASKIN: Multicentric Randomized Phase I/II Study to Evaluate Efficacy of Trifluridine/Tipiracil Plus XB2001 (Anti-IL-1α True Human Antibody) Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine
Essai Clinique (Centre Georges-François Leclerc)   12 février 2024
Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should mutation research be recommended in everyday practice?
Therapeutic advances in gastroenterology   17 janvier 2024
Sulconazole inhibits PD-1 expression in immune cells and cancer cells malignant phenotype through NF-κB and calcium activity repression.
Frontiers in immunology   05 janvier 2024
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
British journal of cancer   15 décembre 2023
MegaMOST - A Multicenter, Open-label, Biology Driven, Phase II Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations /Characteristics in Advanced / Metastatic Tumors.
Essai Clinique (Centre Léon-Bérard)   16 novembre 2023
Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study.
JNCI cancer spectrum   23 octobre 2023
1520P Perioperative treatment in resectable gastric cancer with spartalizumab combined with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT): The GASPAR phase II trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
625P Efficacy and safety of the combination of encorafenib and cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: An AGEO real-world multicentre study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023